Status:

COMPLETED

Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer

Lead Sponsor:

Hellenic Oncology Research Group

Collaborating Sponsors:

University Hospital of Crete

Conditions:

Breast Cancer

Eligibility:

FEMALE

19-75 years

Phase:

PHASE3

Brief Summary

The combination of vinorelbine and gemcitabine seems to be an important part of the chemotherapy regimens used in metastatic breast cancer patients following treatment failure with the combination of ...

Detailed Description

This trial will compare the efficacy of combination treatment with Vinorelbine and Gemcitabine versus Capecitabine monotherapy in metastatic breast cancer patients following treatment failure with the...

Eligibility Criteria

Inclusion

  • Age 19-75 years.
  • Performance status World Health Organization (WHO) 0-2.
  • Histologically confirmed breast adenocarcinoma.
  • Clinical or radiological evidence of metastatic disease that has progressed after combination treatment of a taxane and an anthracycline (Taxotere + Mitoxantrone or Taxotere + Farmorubicine).
  • Measurable disease.
  • No metastatic central nervous system (CNS) disease.
  • Less than 25% of myeloproductive bone marrow irradiated.
  • Adequate bone marrow function (absolute neutrophil count \> 1000/mm\^3, platelet count \> 100000/mm\^3, hemoglobin \> 9 gr/mm\^3).
  • Adequate liver (bilirubin \< 1.5 times upper limit of normal and SGOT/SGPT \< 2 times upper limit of normal) and renal function (creatinine \< 2 mg/dl).
  • Informed consent.

Exclusion

  • Pregnancy or nursing.
  • Positive pregnancy test.
  • Psychiatric illness or social situation that would preclude study compliance.
  • Other concurrent uncontrolled illness.
  • Other invasive malignancy within the past 5 years except nonmelanoma skin cancer.

Key Trial Info

Start Date :

April 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2009

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT00431106

Start Date

April 1 2002

End Date

January 1 2009

Last Update

September 28 2009

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University Hospital of Crete

Heraklion, Crete, Greece, 71110

2

University General Hospital of Alexandroupolis, Dept. of Medical Oncology

Alexandroupoli, Greece

3

"IASO" General Hospital of Athens, 1st Dept. of Medical Oncology

Athens, Greece

4

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dept. of Internal Medicine

Athens, Greece